Stockscreener 앱 받기
572.50
0.10%
0.59
전일 마감가:
$571.91
열려 있는:
$574.15
하루 거래량:
1.65M
Relative Volume:
0.72
시가총액:
$216.18B
수익:
$43.74B
순이익/손실:
$6.59B
주가수익비율:
33.09
EPS:
17.3021
순현금흐름:
$6.11B
1주 성능:
+6.23%
1개월 성능:
+22.33%
6개월 성능:
+34.18%
1년 성능:
+2.71%
1일 변동 폭
$569.79
$575.82
1주일 범위
$540.00
$578.24
52주 변동 폭
$385.46
$610.97
써모 피셔 사이언티픽 Stock (TMO) Company Profile
명칭
Thermo Fisher Scientific Inc
전화
(781) 622-1000
주소
168 THIRD AVENUE, WALTHAM, MA
TMO을(를) 다른 주식과 비교
| 주식 | 가격 | 시가총액 | 매출 | 순이익 | 현금흐름 | 주당 순 이익 |
|---|---|---|---|---|---|---|
TMO
Thermo Fisher Scientific Inc
|
572.50 | 215.96B | 43.74B | 6.59B | 6.11B | 17.30 |
|
DHR
Danaher Corp
|
223.01 | 157.33B | 24.27B | 3.50B | 5.02B | 4.8589 |
|
IDXX
Idexx Laboratories Inc
|
640.85 | 51.09B | 4.04B | 985.66M | 774.34M | 12.01 |
|
A
Agilent Technologies Inc
|
148.03 | 41.80B | 6.79B | 1.22B | 1.09B | 4.2644 |
|
IQV
Iqvia Holdings Inc
|
220.52 | 37.38B | 15.70B | 1.24B | 2.01B | 6.9036 |
써모 피셔 사이언티픽 Stock (TMO) Upgrades & Downgrades
| 날짜 | 액션 | 분석자 | 등급 변경 |
|---|---|---|---|
| 2025-09-11 | 업그레이드 | Barclays | Equal Weight → Overweight |
| 2025-08-19 | 개시 | William Blair | Outperform |
| 2025-07-24 | 다운그레이드 | HSBC Securities | Buy → Hold |
| 2025-07-11 | 업그레이드 | Scotiabank | Sector Perform → Sector Outperform |
| 2025-07-09 | 다운그레이드 | UBS | Buy → Neutral |
| 2025-01-10 | 업그레이드 | Bernstein | Mkt Perform → Outperform |
| 2024-12-23 | 개시 | Scotiabank | Sector Perform |
| 2024-10-14 | 개시 | Redburn Atlantic | Buy |
| 2024-10-01 | 개시 | Stephens | Overweight |
| 2024-08-28 | 개시 | Wells Fargo | Overweight |
| 2024-06-03 | 재개 | Jefferies | Buy |
| 2024-03-18 | 재개 | Citigroup | Neutral |
| 2024-01-24 | 다운그레이드 | Barclays | Overweight → Equal Weight |
| 2024-01-08 | 다운그레이드 | Bernstein | Outperform → Mkt Perform |
| 2023-12-18 | 개시 | HSBC Securities | Buy |
| 2023-12-13 | 개시 | Wolfe Research | Outperform |
| 2023-10-26 | 다운그레이드 | KeyBanc Capital Markets | Overweight → Sector Weight |
| 2023-10-25 | 업그레이드 | Wells Fargo | Underweight → Equal Weight |
| 2023-09-28 | 개시 | Bernstein | Outperform |
| 2023-09-06 | 재개 | Citigroup | Buy |
| 2023-07-19 | 개시 | Raymond James | Outperform |
| 2023-07-19 | 재확인 | Robert W. Baird | Outperform |
| 2023-07-13 | 업그레이드 | Credit Suisse | Neutral → Outperform |
| 2023-04-04 | 재확인 | Barclays | Overweight |
| 2022-12-14 | 개시 | Deutsche Bank | Buy |
| 2022-12-07 | 개시 | RBC Capital Mkts | Outperform |
| 2022-10-27 | 다운그레이드 | The Benchmark Company | Buy → Hold |
| 2022-08-25 | 개시 | Credit Suisse | Neutral |
| 2022-04-25 | 다운그레이드 | Wells Fargo | Equal Weight → Underweight |
| 2022-01-26 | 재개 | Barclays | Overweight |
| 2021-10-20 | 업그레이드 | Citigroup | Neutral → Buy |
| 2021-10-15 | 재개 | Cowen | Outperform |
| 2021-08-05 | 재개 | Credit Suisse | Outperform |
| 2021-07-16 | 개시 | The Benchmark Company | Buy |
| 2021-03-18 | 업그레이드 | KeyBanc Capital Markets | Sector Weight → Overweight |
| 2021-03-03 | 개시 | Barclays | Overweight |
| 2021-01-08 | 업그레이드 | Credit Suisse | Neutral → Outperform |
| 2020-12-16 | 다운그레이드 | Citigroup | Buy → Neutral |
| 2020-12-02 | 개시 | Goldman | Buy |
| 2020-11-10 | 개시 | KeyBanc Capital Markets | Sector Weight |
| 2020-09-30 | 개시 | Atlantic Equities | Overweight |
| 2020-09-14 | 개시 | Morgan Stanley | Overweight |
| 2020-08-20 | 재개 | JP Morgan | Overweight |
| 2020-07-15 | 업그레이드 | Cleveland Research | Neutral → Buy |
| 2020-07-07 | 재확인 | Needham | Buy |
| 2020-04-23 | 재확인 | Needham | Buy |
| 2020-01-31 | 재확인 | Needham | Buy |
| 2020-01-22 | 개시 | Credit Suisse | Neutral |
| 2020-01-08 | 개시 | Wells Fargo | Equal Weight |
| 2020-01-07 | 개시 | Citigroup | Buy |
| 2019-11-15 | 개시 | Stifel | Buy |
| 2019-07-25 | 재확인 | Needham | Buy |
| 2019-07-16 | 다운그레이드 | Needham | Strong Buy → Buy |
| 2019-05-30 | 개시 | Wolfe Research | Outperform |
| 2019-05-23 | 재확인 | Needham | Strong Buy |
| 2019-04-22 | 재확인 | Needham | Strong Buy |
| 2019-04-16 | 재확인 | BofA/Merrill | Buy |
모두보기
써모 피셔 사이언티픽 주식(TMO)의 최신 뉴스
Chart overlay techniques for tracking Thermo Fisher Scientific Inc.July 2025 Price Swings & Advanced Technical Analysis Signals - newser.com
Why analysts recommend Thermo Fisher Scientific Inc. (Common Stock) (TN80) stockTrade Risk Report & Growth Oriented Trade Recommendations - newser.com
Visual analytics tools that track Thermo Fisher Scientific Inc. performanceJuly 2025 Selloffs & Safe Entry Point Identification - newser.com
Why Thermo Fisher Scientific Inc. (TN8) stock fits value portfoliosPortfolio Update Summary & Daily Stock Momentum Reports - newser.com
Candlestick signals on Thermo Fisher Scientific Inc. stock todayJuly 2025 Highlights & Daily Stock Trend Watchlist - newser.com
Is Thermo Fisher Scientific Inc. stock a top pick in earnings seasonTrade Ideas & Safe Swing Trade Setup Alerts - newser.com
Is Thermo Fisher Scientific Inc. (TN8) stock considered safe havenMarket Movement Recap & High Accuracy Buy Signal Tips - newser.com
Thermo Fisher Scientific: More Upside Likely As Headwinds Continue To Fade And Valuation Still Attractive - Seeking Alpha
Price action breakdown for Thermo Fisher Scientific Inc.Forecast Cut & High Win Rate Trade Alerts - newser.com
Jim Cramer on Thermo Fisher: “Maybe This Stock Can Finally Get its Groove Back” - Insider Monkey
Published on: 2025-10-24 17:56:28 - newser.com
Volatility clustering patterns for Thermo Fisher Scientific Inc.Index Update & Accurate Entry/Exit Alerts - newser.com
How to use Fibonacci retracement on Thermo Fisher Scientific Inc.Trade Entry Report & Verified Swing Trading Watchlist - newser.com
Price momentum metrics for Thermo Fisher Scientific Inc. explainedWeekly Trade Review & Verified Technical Signals - newser.com
Human Combinatorial Antibody Libraries Market to Surge USD 189.57 Million by 2034, Reports Towards Healthcare - GlobeNewswire Inc.
Analysts Offer Insights on Healthcare Companies: Thermo Fisher (TMO) and Intuitive Surgical (ISRG) - The Globe and Mail
Thermo Fisher (TMO US)Strong 3Q25 Performance; Raising Full-Year Guidance - Smartkarma
UBS Maintains Thermo Fisher Scientific (TMO) Neutral Recommendation - Nasdaq
Biopharma Buffer Market Trends, Investment Opportunities, - openPR.com
Thermo Fisher Scientific Launches Industry-First Orbitrap Mass Detector for Environmental and Food Safety Testing - BioSpace
Day 8 of Gains Streak for Thermo Fisher Scientific Stock with 9% Return (vs. 10% YTD) [10/23/2025] - Trefis
Wells Fargo Maintains Thermo Fisher Scientific (TMO) Overweight Recommendation - Nasdaq
Correction to Thermo Fisher Article on Oct. 22 - MarketScreener
Bank of America Securities Reiterates a Buy Rating on Thermo Fisher Scientific (TMO) - MSN
Jamie Murray's Past Picks: Adyen, Thermo Fisher Scientific & Northland Power - BNN Bloomberg
Thermo Fisher Scientific Inc (NYSE:TMO) Topline Grows 5% - FXDailyReport.Com
Thermo Fisher launches lung transplant rejection test - Scientist Live
Analyst TD Cowen Raises Thermo Fisher Scientific (TMO) Price Tar - GuruFocus
Thermo Fisher Scientific price target raised to $654 by TD Cowen - Investing.com
UBS Adjusts Thermo Fisher Scientific Price Target to $590 From $500, Maintains Neutral Rating - MarketScreener
Wells Fargo Raises Price Target for Thermo Fisher Scientific (TM - GuruFocus
HSBC Adjusts Price Target on Thermo Fisher Scientific to $550 From $510, Maintains Hold Rating - MarketScreener
Thermo Fisher Scientific Inc. (NYSE:TMO) Q3 2025 Earnings Call Transcript - Insider Monkey
Thermo Fisher: Recuperation And Macroeconomic Tailwinds Will Unlock Value - Seeking Alpha
Citigroup Maintains Neutral Rating for Thermo Fisher Scientific (TMO), Raises PT to $580 | TMO Stock News - GuruFocus
Leerink Partners Maintains Thermo Fisher Scientific (TMO) Outperform Recommendation - Nasdaq
Deutsche Bank Adjusts Price Target on Thermo Fisher Scientific to $620 From $530, Maintains Buy Rating - 富途牛牛
Citigroup Adjusts Price Target on Thermo Fisher Scientific to $580 From $500, Maintains Neutral Rating - 富途牛牛
Wells Fargo Adjusts PT on Thermo Fisher Scientific to $635 From $565, Maintains Overweight Rating - 富途牛牛
Barclays Adjusts PT on Thermo Fisher Scientific to $625 From $585, Maintains Overweight Rating - 富途牛牛
JPMorgan Adjusts PT on Thermo Fisher Scientific to $675 From $650, Maintains Overweight Rating - MarketScreener
TD Cowen Adjusts Price Target on Thermo Fisher Scientific to $654 From $612, Maintains Buy Rating - MarketScreener
Wolfe Research Adjusts PT on Thermo Fisher Scientific to $615 From $525, Maintains Outperform Rating - MarketScreener
Earnings Call Summary | Thermo Fisher Scientific(TMO.US) Q3 2025 Earnings Conference - 富途牛牛
Genomic Cancer Testing Market is Going to Booming Growth 2025 - openPR.com
Magnetic Beads Market Size, Trends 2032 By Key Players- Thermo - openPR.com
What makes Thermo Fisher Scientific Inc. (TN8) stock appealing to growth investorsJuly 2025 Analyst Calls & Intraday High Probability Setup Alerts - newser.com
Thermo Fisher Launches Carbon Calculator for Clinical Trials - Sustainability Magazine
Thermo Fisher Scientific (TMO): Assessing Valuation After Upbeat Q3 Results and Raised Outlook - Yahoo Finance
Shigella Test Kit Market Is Booming Worldwide 2025-2032 | Thermo - openPR.com
Wilms Tumor Protein Market Is Booming So Rapidly | Abcam plc, - openPR.com
써모 피셔 사이언티픽 (TMO) 재무 분석
매출
순이익
현금흐름
주당 순 이익
0.13%
0.24%
자본화:
|
볼륨(24시간):